Questions 50-51: Did the recipient develop COVID-19 (SARS-CoV-2) since the date of the last report?
SARS-CoV-2 is a novel virus belonging to the coronavirus (CoV) family that emerged in December 2019. The disease caused by this new CoV is known as COVID-19 (coronavirus disease 2019). The new virus is highly contagious and was officially declared a pandemic in March 2020. Transmission is believed to be from person to person through respiratory droplets from coughing and sneezing . Testing for COVID-19 is generally performed on specimens collected from a nasal swab or sputum sample .
As a result of the global COVID-19 pandemic, the U.S. Food and Drug Administration granted Sherlock Biosciences an emergency use of authorization (EUA) for its COVID-19 diagnostic assay, CRISPR. Although still in its infancy in real-life application, positive results by this method should be reported, even if tandem testing by other method(s) (i.e., PCR) indicate a negative result. If the CRISPR results are unclear, seek physician clarification.
Indicate whether or not the recipient has ever had a known COVID-19 (SARS-CoV-2) infection, based on a positive test result, at any during the current reporting period.
If the recipient has had a documented COVID-19 (SARS-CoV-2) infection, report “yes” and report the first date of the pathological diagnosis in question 51.
If the recipient has not had a documented COVID-19 (SARS-CoV-2) infection, report “no” and continue with question 52.
Need more help with this?
Don’t hesitate to contact us here.